We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $108M
1-Year Est. Return 137.54%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+137.54%
3 Year Est. Return
+42.74%
5 Year Est. Return
-38.65%
10 Year Est. Return
–
AUM
$32.5M
AUM Growth
-$44M
Cap. Flow
-$50M
Cap. Flow %
-153.82%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CGON icon
CG Oncology
CGON
+$49.6M
2
CSTL icon
Castle Biosciences
CSTL
+$363K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRGX
1
DELISTED
CARGO Therapeutics
CRGX
$16.8M 51.8%
912,000
– –
ALMS
2
Alumis Inc
ALMS
$3B
$8.43M 25.96%
789,618
– –
CGON icon
3
CG Oncology
CGON
$7B
$6.17M 18.99%
163,456
-1,414,888
-90% -$49.6M
CSTL icon
4
Castle Biosciences
CSTL
$1.05B
$642K 1.98%
22,503
-14,244
-39% -$363K
PYXS icon
5
Pyxis Oncology
PYXS
$277M
$254K 0.78%
69,303
– –
SGMT icon
6
Sagimet Biosciences
SGMT
$668M
$158K 0.49%
57,190
– –

Similar funds

YEPX
Yorktown Energy Partners XI New York $108M AUM 57.73% 1-Year Est. Return
WIM
Walsky Investment Management Wyomissing, Pennsylvania $108M AUM
SF
Schuylkill Financial Wyomissing, Pennsylvania $108M AUM
BC
Bayforest Capital London, United Kingdom $108M AUM 45.71% 1-Year Est. Return
MMRF
Michelson Medical Research Foundation Los Angeles, California $108M AUM 29.95% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $108M AUM
SA
SPWM Advisors Traverse City, Michigan $108M AUM
UFA
Unify Financial Advisors Clearwater, Florida $108M AUM

Yu Fan's Q3 2024 Portfolio in Review

As of Q3 2024, Yu Fan held 6 positions worth $32.5M, down 58% from $76.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan withdrew a net $50M in Q3 2024, reducing 2 holdings. Its largest reduction was CG Oncology, cutting an estimated $49.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Yu Fan's biggest Q3 2024 reduction was CG Oncology, cutting an estimated $49.6M.
  • Yu Fan's ten largest holdings make up 100% of its $32.5M portfolio in Q3 2024.
  • Yu Fan opened 0 new positions and closed 0 in Q3 2024.
  • Yu Fan's portfolio value fell 58% quarter-over-quarter to $32.5M.

Based on Yu Fan's 13F filing for Q3 2024, filed 14 Nov 2024.